Innovation Partnerships

Mila Ventures is building the Venture Scientist platform: an integrated venture-creation engine designed to translate frontier AI research into world-class companies - rooted in Canada, built for the world. Mila Ventures operates within Mila, a prestigious AI research institute based in Montréal, founded by Yoshua Bengio, one of the godfathers of modern artificial intelligence and a pioneer of deep learning. The platform brings together: Mila Venture Studio (co-creating companies with professors, students, and entrepreneurs) Mila Accelerator (early company building and scaling) Venture Scientist Academy (training researchers to become venture builders) The Mila Venture Fund (in formation) We operate at the intersection of AI research, venture creation, and capital, working closely with Mila's globally renowned researchers, students, founders, investors, corporate partners, and public institutions.

We are a unique commercialisation fund helping researchers from our partner research organisations turn their ideas into products and services. We support innovations that solve market problems and create a positive impact for our community. Uniseed invests over a broad range of technology sectors and has exited twelve investments, to date. HOW WE HELPSeed capital investment: We invest in your innovation to help you progress and de-risk from both a technical and commercial perspective. Expert guidance: We believe in supporting your progress through collaboration and mentoring. Network access: You will have the ability to access Uniseed’s network of industry experts, co-investors and start-up experts. Commercialisation: We help you build your strategy, manage your intellectual property and identify commercial partners. Rewards & recognition: Boost career profile, publications, conferences, patent publications and increase your visibility. Make an impact: Impact our community by solving market problems through your innovation. Our ProcessMake Contact: Get in contact through your commercialisation office or directly with us. Initial meetings and discussions will start with an Investment Manager. Tell us about your innovative opportunity and we will assist in identifying the most appropriate pathway forward. Pitch to Us: Promising eligible opportunities will have the opportunity to pitch to the Uniseed Investment Committees (which convenes monthly) and receive feedback. Due Diligence & Negotiation: Uniseed conducts detailed due diligence on your opportunity which may include further presentation(s) to our investment committee. We syndicate promising deals with your co-investors (as required) Investment & Growth: Investment capital is provided. Uniseed provides expert guidance and access to networks. We also help to develop, grow and scale your innovation. Impact & Exit: Generate impact through your innovation. Receive awards and recognition. Exit and achieve a return for shareholders.

Since its genesis at the University of Oxford in 2015, Panacea Innovation has partnered with some of the world’s best sci-entrepreneurs, research bodies, universities and corporates to build more than 280 companies that offer cutting-edge solutions - curating a portfolio of more than GBP£300m in value. Panacea Innovation’s venturing activities are delivered through two complementary arms: Panacea Stars - a technology translation, commercialisation and R&D arm - and Panacea Ventures, the investment management one.

AdBio partners (formerly Advent France Biotechnology) is a venture capital firm investing in early stage life sciences companies in Europe. AdBio partners’ unique strategy combines early-stage investments in promising startups and strong entrepreneurial support to enable and strengthen the company’s growth. As an early-stage investor, we act as a catalyst to create companies based on innovations coming from academic research. We have established relationships with leading research institutions and technology transfer offices in Europe and benefit from the support of strong network of scientific, clinical, industry and financial partners. The operational team is managed by Alain Huriez, MD, Chairman and Managing Partner, and Geoffroy de Ribains, Managing Partner. The team includes seasoned investment professionals with long-standing track records in entrepreneurial ventures, combined with strong scientific, medical and operational expertise.

The EFL program runs from October – May each year. Founders are not required to have a New York University affiliation and do not have to relocate to New York. The program is free for founders – no equity or fees are taken. Other program benefits include: Executive mentorship: Business leaders, serial entrepreneurs, and seasoned executives will help you craft your company’s vision through time-bound, performance-based goals. Access to leading VCs and Investors: Investment mentors will guide you in successfully raising capital, make connections with New York’s investment community, and may even invest in your startup. Guidance from leading scientists: Prominent scientists and researchers across a myriad of verticals will help you mold your technology development strategy. Business development: NYU Stern’s MBA students will support you in a variety of ways based on your specific business needs. EFL team guidance: The EFL’s expert team will keep you on track to accomplishing your goals by optimizing your access to mentors, MBA students, and other resources throughout the program. Corporate services: EFL’s corporate partners donate many hours and hundreds of thousands of dollars worth of in-kind legal, financial, and technological services. Mentorship from business leaders and scientists Endless Frontier Labs’ mentors are business leaders, investors, and scientists drawn from New York’s thriving business and academic institutions and beyond. Our mentors commit substantial time to provide startups with the best advice and connections to maximize their chances of success. Our ValuesFounder Friendly: We are committed to provide programming in the long-term interests of entrepreneurs. We do not take equity or fees from startups. Each core aspect of the program is in the best interests of founders before, during, and after the program. Inclusivity: We are committed to building an inclusive, equitable, and just community now and for our future. We will provide an environment that is free of bias, prejudice, discrimination, and harassment. Performance Orientation: We are committed to (a) selecting founders with extraordinarily bold, new ideas, (b) providing intimate access to outstanding mentors, and (c) eliciting maximum effort from mentors and founders to accelerate the societal impact of breakthrough science.

We have been in the ecosystem for more than 20 years each. Our Tech Transfer acceleration programmes have accompanied more than 100 spin-offs over these years. We have an ongoing relationship with universities and research centres. Having been entrepreneurs before helps us understand first-hand the challenges faced by our entrepreneurs. Our knowledge of Tech transfer. Our multidisciplinary team of successful entrepreneurs.